205 related articles for article (PubMed ID: 31858647)
21. MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin.
Zhao H; Xie YZ; Xing R; Sun M; Chi F; Zeng YC
Cell Oncol (Dordr); 2017 Aug; 40(4):357-365. PubMed ID: 28567715
[TBL] [Abstract][Full Text] [Related]
22. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
23. Association of kinesin family member 2A with increased disease risk, deteriorative clinical characteristics, and shorter survival profiles in acute myeloid leukemia.
Ding T; Li J; Sun J; Fan X; Shi C; Zhou D; Deng R
Braz J Med Biol Res; 2020; 54(2):e9173. PubMed ID: 33331418
[TBL] [Abstract][Full Text] [Related]
24. Katanin P80 correlates with larger tumor size, lymph node metastasis, and advanced TNM stage and predicts poor prognosis in non-small-cell lung cancer patients.
Ye Q; Zhang M; Yin Y
J Clin Lab Anal; 2020 Apr; 34(4):e23141. PubMed ID: 31944409
[TBL] [Abstract][Full Text] [Related]
25. The clinical value of kinesin superfamily protein 2A in hepatocellular carcinoma.
Liu W; Xu C; Meng Q; Kang P
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101527. PubMed ID: 33713978
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of KIF2A inhibits gastric cancer cell invasion via suppressing MT1-MMP.
Zhao P; Lan F; Zhang H; Zeng G; Liu D
Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1010-1018. PubMed ID: 29781531
[TBL] [Abstract][Full Text] [Related]
27. AKIP1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non-small cell lung cancer: Results of a retrospective study.
Liu Y; Tian J; Qin D; Liu J; Xie Y
J Clin Lab Anal; 2020 Apr; 34(4):e23128. PubMed ID: 31782840
[TBL] [Abstract][Full Text] [Related]
28. Role of KIF2A in the progression and metastasis of human glioma.
Zhang X; Ma C; Wang Q; Liu J; Tian M; Yuan Y; Li X; Qu X
Mol Med Rep; 2016 Feb; 13(2):1781-7. PubMed ID: 26707290
[TBL] [Abstract][Full Text] [Related]
29. Aberrant Kif2a and Ki67 expression predicts poor survival in laryngeal squamous cell carcinoma.
Zhang Q; Zhang W; Zhang J; Xu H; You Y
Auris Nasus Larynx; 2016 Aug; 43(4):433-9. PubMed ID: 26602436
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
[TBL] [Abstract][Full Text] [Related]
31. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
[TBL] [Abstract][Full Text] [Related]
32. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
[TBL] [Abstract][Full Text] [Related]
33. High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
Li X; Liu M; Zhang Z; Zhang L; Liang X; Sun L; Zhong D
Thorac Cancer; 2019 May; 10(5):1103-1110. PubMed ID: 30907518
[TBL] [Abstract][Full Text] [Related]
34. KIF2A Overexpression and Its Association with Clinicopathologic Characteristics and Poor Prognoses in Patients with Gastric Cancer.
Zhang S; Huang F; Wang Y; Song Q; Yang X; Wu H
Dis Markers; 2016; 2016():7484516. PubMed ID: 27773961
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
36. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of KIF2A is Suppressed by miR-206 and Associated with Poor Prognosis in Ovarian Cancer.
Sheng N; Xu YZ; Xi QH; Jiang HY; Wang CY; Zhang Y; Ye Q
Cell Physiol Biochem; 2018; 50(3):810-822. PubMed ID: 30352438
[TBL] [Abstract][Full Text] [Related]
38. Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
Liang X; Xia R
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34792179
[TBL] [Abstract][Full Text] [Related]
39. Correlation of integrin alpha 7 with clinicopathological characteristics and survival profiles, as well as its regulatory role in cell proliferation, apoptosis, and stemness in non-small-cell lung cancer.
Xia D; Chen B; Yang X
J Clin Lab Anal; 2019 Oct; 33(8):e22973. PubMed ID: 31418948
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of long non-coding RNA SNHG16 correlates with tumor progression and poor prognosis in non-small cell lung cancer.
Han W; Du X; Liu M; Wang J; Sun L; Li Y
Int J Biol Macromol; 2019 Jan; 121():270-278. PubMed ID: 30287374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]